Croma-Pharma

Focus: Croma-Pharma is an Austrian aesthetic medicine and ophthalmology specialist with a diversified portfolio of dermal fillers, botulinum toxin formulations, and ophthalmic products. The company operates as a public entity focused on minimally invasive aesthetic and surgical applications.

Ophthalmology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Croma-Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow Croma-Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

4 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Princess® VOLUME

Nasolabial Folds, Facial Lipoatrophy

Growth

Established hyaluronic acid filler with multiple formulations targeting mid-face volume replacement.

Saypha® VOLUME Lidocaine

Moderate to Severe Midface Volume Deficit

Help build intelligence for Croma-Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Letybo®

Glabellar Lines

N/A

Clinical Trials (1)

NCT07374965A Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatment With Botulinum Neurotoxin A

N/A

Thioderm Strong

Mid Face Volume Deficit

N/A

Clinical Trials (1)

NCT06128109THIODERM STRONG Compared to Juvéderm® VOLUMA® Lidocaine for the Treatment of Midface Volume Deficit

N/A

THIODERM ELATE

Lip; Anomaly

N/A

Clinical Trials (1)

NCT06133153THIODERM ELATE for Volume Augmentation in Lips

N/A

Princess® RICH

Lateral Canthal Lines

N/A

Clinical Trials (1)

NCT03923634Princess® RICH for the Correction of Fine Lines

N/A

etacoat

Cataract Surgery

N/A

Clinical Trials (1)

NCT03644875Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber

N/A

Princess® VOLUME

Nasolabial Folds

N/A

Clinical Trials (1)

NCT01798498Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess® VOLUME in Nasolabial Folds

N/A

etafill

Cataract Surgery

N/A

Clinical Trials (1)

NCT03644862Study of Etafill in Patients With Cataract Surgery Via the Anterior Chamber

N/A

Hyaluronic acid dermal filler

Wrinkle Reduction

N/A

Clinical Trials (1)

NCT07475455Filler Post Market Survey (FIPS)

N/A

Princess® FILLER

Facial Lipoatrophy

N/A

Clinical Trials (1)

NCT03050723Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

N/A

Princess FILLER Lidocaine

Correction of Nasolabial Folds

N/A

Clinical Trials (1)

NCT03611491Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds

N/A

Saypha Volume Lidocaine

Moderate to Severe Nasolabial Folds

N/A

Clinical Trials (1)

NCT04883632Saypha® Volume LIdocaine in Nasolabial Folds

N/A

Saypha® FILLER Lidocaine

Abnormal Lip

N/A

Clinical Trials (1)

NCT04917588Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation

N/A

Princess Filler Lidocaine

Dermatological Non-Disease

N/A

Clinical Trials (1)

NCT03990883Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)

N/A

Princess® VOLUME Lidocaine

Nasolabial Fold, Hypoplastic

N/A

Clinical Trials (1)

NCT03050710Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds

N/A

Letybo®

Glabellar Lines

N/A

Clinical Trials (1)

NCT07398755Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure

N/A

Thioderm Elate

Lip Abnormality

N/A

Clinical Trials (1)

NCT06135337THIODERM ELATE for Augmentation of Very Thin, Thin, and Moderately Thick Lips

N/A

THIODERM STRONG

Correction of Nasolabial Folds

N/A

Clinical Trials (1)

NCT03650218Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds

N/A

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Lateral Canthal Lines (LCL)

N/A

Clinical Trials (1)

NCT07492277A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

N/A

Princess® VOLUME

Facial Lipoatrophy

N/A

Clinical Trials (1)

NCT03050749Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

N/A

Saypha® Rich

Perioral Wrinkles

N/A

Clinical Trials (1)

NCT07398768Prospective, Non-interventional Study Assessing Perioral Rejuvenation Procedure

N/A

Dermal filler for midface deficit

Midface Volume Deficit

N/A

Clinical Trials (1)

NCT03532126A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

N/A

Chitosan-N-acetylcysteine eye drops

Dry Eye Syndrome

Phase 1

Clinical Trials (1)

NCT01747616Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses

Phase 1

Hyaluronan Thiomer i.o. implant

Open Angle Glaucoma

Phase 1

Clinical Trials (1)

NCT01887873Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy

Phase 1

Botulinum toxin A "BoNT/A-DP"

Frown Lines

Phase 2

Clinical Trials (1)

NCT04763265Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

Phase 2

Chitosan- N- Acetylcysteine eye drops

Dry Eye Syndrome

Phase 2

Clinical Trials (1)

NCT01753752Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation

Phase 2

Botulinum Toxin A

Glabellar Frown Lines

Phase 3

Clinical Trials (1)

NCT02677298Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I

Phase 3

saypha® VOLUME Lidocaine

Moderate to Severe Midface Volume Deficit

Phase 3

Clinical Trials (1)

NCT05386030Saypha® VOLUME Lidocaine for Midface Augmentation

Phase 3

Botulinum Toxin A

Glabellar Frown Lines

Phase 3

Clinical Trials (1)

NCT02677805Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

Phase 3

Botulinum Toxin A

Glabellar Frown Lines

Phase 3

Clinical Trials (1)

NCT03985982Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

Phase 3

Croma-Pharma

About Croma-Pharma

Why Work Here

Key Products

Watch Out For

Pipeline & Clinical Trials

Open Jobs (0)